Advertisement for orthosearch.org.uk
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

General Orthopaedics

BIOMIMETIC OSTEOCHONDRAL SCAFFOLD AS A RELIABLE ALTERNATIVE TO PROSTHETIC SURGERY IN TREATING OF LATE STAGE SPONK

The International Society for Technology in Arthroplasty (ISTA), 28th Annual Congress, 2015. PART 4.



Abstract

Purpose

To assess the reliability of a biomimetic osteochondral scaffold Maioregen (Finceramica Faenza SpA, Faenza, Italt) as a salvage and joint-preserving procedure in the treatment of late stages of osteonecrosis of the knee.

Methods

Nine active patients aged under 65 year presenting with clinical and radiological signs of SPONK were treated with a biomimetic osteochondral scaffold. All patients were clinically evaluated preoperatively and yearly with a minimum follow-up of 2 years. Subjective IKDC and Lysholm Knee Scale were used to assess clinical outcome. Pre-operative and post-operative pain was quantified with VAS scale. Activity level were evaluated pre-operatively and at follow-up according to Tegner Activity Scale.

Results

Subjective IKDC (35 ± 14.5 to 75.7 ± 20) and Lysholm Knee Scale (49.7 ± 17.9 to 86.6 ± 12.7) significantly improved from pre-operative evaluation (p < .01). VAS decreased from a mean pre-operative value of 6.3 ± 2.5 to 1.6 ± 2.7 at 2 years follow-up. Tegner Activity Scale doesn't show significant differences between pre-operative values and those obtained at two-year follow up.

Two of nine patients returned to be symptomatic after 18 months from the implants and progressed to condylar collapse, despite the joint-preserving treatment, and underwent a total knee arthroplasty.

Conclusions

Biomimetic scaffold can be a valid option in surgical treatment of SPONK in young active patients. Use of this surgical technique, originally developed for OCD, gives good clinical results at a mid-term follow up also in treatment of osteonecrosis and could postpone or even spare joint replacement procedures.


*Email: